Mantas Jesus B
SEC CIK 1777331 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | Dir | 11.3K | — | — | 6 | 2021-07-01 | 2026-06-09 |
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
| 11 | Mantas Jesus B | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 17:44 | 2026-06-09 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +1,505 | 11.3K | +15% | $0 | |
| 2025-06-18 | 2025-06-17 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +2,370 | 9,758 | +32% | $0 | |
| 2024-06-25 | 2024-06-21 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +1,340 | 7,388 | +22% | $0 | |
| 2023-06-28 | 2023-06-26 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +960 | 6,048 | +19% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +1,370 | 5,088 | +37% | $0 | |
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | Mantas Jesus B | Dir | A - Grant | $0.00 | +775 | 3,718 | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations